Humanization of a strategic CD3 epitope enables evaluation of clinical T-cell engagers in a fully immunocompetent in vivo model.
Zorn JA, Wheeler ML, Barnes RM, Kaberna J, Morishige W, Harris M, Huang RY, Lohre J, Chang YC, Chau B, Powers K, Schindler I, Neradugomma N, Thomas W, Liao X, Zhou Y, West SM, Wang F, Kotapati S, Chen G, Yamazoe S, Kosenko A, Dollinger G, Sproul T, Rajpal A, Strop P.
Zorn JA, et al. Among authors: dollinger g.
Sci Rep. 2022 Mar 3;12(1):3530. doi: 10.1038/s41598-022-06953-7.
Sci Rep. 2022.
PMID: 35241687
Free PMC article.